Skip to main content

Advertisement

SpringerLink
Log in

Organizing services for cardiovascular prevention

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

With an aging population, cardiovascular disease (CVD) prevalence will continue to increase for at least the next 30 years. Current clinical trial evidence expands the indications for aggressive treatment of risk factors. Concurrently, the use of new screening and diagnostic technologies will expand the number of identified high-risk individuals requiring clinical care. These likely scenarios will force efficient resource allocation. The impression of the authors is that new models of shared responsibilities of care are needed to enable CVD prevention. All stages of care for those with CVD should entail cooperation among nurses, pharmacists, primary care providers, and cardiovascular specialists in delivering comprehensive, evidence-based care. The persistent treatment gap between current knowledge and clinical practice suggests old models of acute patient care by specialists require revision into fundamentally different systems of long-term care by a team of providers such as that proposed by the Chronic Care Model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227–239.

    Article  PubMed  Google Scholar 

  2. Cannon CP, Braunwald E, McCabe CH, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004, 350:1495–1504.

    Article  PubMed  CAS  Google Scholar 

  3. Hennekens CH, Sacks FM, Tonkin A, et al.: Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med 2004, 164:40–44.

    Article  PubMed  CAS  Google Scholar 

  4. Sever PS, Dahlof B, Poulter NR, et al.: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003, 361:1149–1158.

    Article  PubMed  CAS  Google Scholar 

  5. Pearson TA, Laurora I, Chu H, Kafonek S: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000, 160:459–467.

    Article  PubMed  CAS  Google Scholar 

  6. Davidson MH, Maki KC, Pearson TA, et al.: Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol 2005, 96:556–563.

    Article  PubMed  Google Scholar 

  7. Swanson JR, Pearson TA: Screening family members at high risk for coronary disease. Why isn’t it done? Am J Prev Med 2001, 20:50–55.

    CAS  Google Scholar 

  8. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for patients with chronic illness. JAMA 2002, 288:1775–1779.

    Article  PubMed  Google Scholar 

  9. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA 2002, 288:1909–1914.

    Article  PubMed  Google Scholar 

  10. Olivarius NF, Beck-Nielsen H, Andreasen AH, et al.: Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001, 323:970–975.

    Article  PubMed  CAS  Google Scholar 

  11. Mehta RH, Montoye CK, Gallogly M, et al.: Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA 2002, 287:1269–1276.

    Article  PubMed  Google Scholar 

  12. LaBresh KA, Ellrodt AG, Gliklich R, et al.: Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 2004, 164:203–209.

    Article  PubMed  Google Scholar 

  13. Pearson TA, Blair SN, Daniels SR, et al.: AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002, 106:388–391.

    Article  PubMed  Google Scholar 

  14. Snow V, Barry P, Fihn SD, et al.: Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. Ann Intern Med 2004, 141:57–64.

    PubMed  Google Scholar 

  15. Snow V, Weiss KB, Mottur-Pilson C; Clinical Efficacy Assessment Subcommittee of the American College of Physicians: The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med 2003, 138:587–592.

    PubMed  Google Scholar 

  16. Vijan S, Hayward RA; American College of Physicians: Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med 2004, 140:650–658.

    PubMed  CAS  Google Scholar 

  17. Casalino L, Gillies RR, Shortell SM, et al.: External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases. JAMA 2003, 289:434–441.

    Article  PubMed  Google Scholar 

  18. Ornstein S, Jenkins RG, Nietert PJ, et al.: A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial. Ann Intern Med 2004, 141:523–532.

    PubMed  Google Scholar 

  19. Smith SC Jr: Clinical treatment of dyslipidemia: practice patterns and missed opportunities. Am J Cardiol 2000, 86:62L–65L.

    Article  PubMed  Google Scholar 

  20. Merz CN, Mensah GA, Fuster V, et al.: Task force #5—the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference. J Am Coll Cardiol 2002, 40:641–651.

    Article  PubMed  Google Scholar 

  21. Lenfant C: Conquering cardiovascular disease: progress and promise. JAMA 1999, 282:2068–2070.

    Article  PubMed  CAS  Google Scholar 

  22. Ades PA, Balady GJ, Berra K: Transforming exercise-based cardiac rehabilitation programs into secondary prevention centers: a national imperative. J Cardiopulm Rehabil 2001, 21:263–272.

    Article  PubMed  CAS  Google Scholar 

  23. Genest JJ, McNamara JR, Salem DN, Schaefer EJ: Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol 1991, 67:1185–1189.

    Article  PubMed  CAS  Google Scholar 

  24. Wenger NK, Froelicher ES, Smith LK, et al.: Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute. Clin Pract Guidel Quick Ref Guide Clin 1995, Oct(17):1–23.

  25. Haskell WL, Alderman EL, Fair JM, et al.: Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994, 89:975–990.

    PubMed  CAS  Google Scholar 

  26. Friedman DB, Williams AN, Levine BD: Compliance and efficacy of cardiac rehabilitation and risk factor modification in the medically indigent. Am J Cardiol 1997, 79:281–285.

    Article  PubMed  CAS  Google Scholar 

  27. Cannistra LB, O’Malley CJ, Balady GJ: Comparison of outcome of cardiac rehabilitation in black women and white women. Am J Cardiol 1995, 75:890–893.

    Article  PubMed  CAS  Google Scholar 

  28. Hunt DL, Haynes RB, Hanna SE, Smith K: Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 1998, 280:1339–1346.

    Article  PubMed  CAS  Google Scholar 

  29. Kaushal R, Shojania KG, Bates DW: Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003, 163:1409–1416.

    Article  PubMed  Google Scholar 

  30. McDonald CJ: Protocol-based computer reminders, the quality of care and the non-perfectability of man. N Engl J Med 1976, 295:1351–1355.

    Article  PubMed  CAS  Google Scholar 

  31. Irvine J, Baker B, Smith J, et al.: Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosom Med 1999, 61:566–575.

    PubMed  CAS  Google Scholar 

  32. Litvin CB, Ornstein SM, Anthony WE Jr, Tanner D: Quality improvement using electronic medical records: a case study of a high-performing practice. Top Health Inf Manage 2001, 22:59–64.

    PubMed  CAS  Google Scholar 

  33. Feifer C, Ornstein SM, Nietert PJ, Jenkins RG: System supports for chronic illness care and their relationship to clinical outcomes. Top Health Inf Manage 2001, 22:65–72.

    PubMed  CAS  Google Scholar 

  34. Horwitz RI, Viscoli CM, Berkman L, et al.: Treatment adherence and risk of death after a myocardial infarction. Lancet 1990, 336:542–545.

    Article  PubMed  CAS  Google Scholar 

  35. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project [no authors listed]. N Engl J Med 1980, 303:1038–1041.

  36. Levine DM: Behavioral and psychosocial factors, processes, and strategies. In Primer in Preventive Cardiology. Edited by Pearson TA, et al. American Heart Association; Dallas, TX: 1994:217–226.

    Google Scholar 

  37. Berg JS, Dischler J, Wagner DJ, et al.: Medication compliance: a healthcare problem. Ann Pharmacother 1993, 27(9 suppl):S1–S24.

    PubMed  CAS  Google Scholar 

  38. Haynes RB, Sackett DL, Taylor DW, et al.: Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions. Clin Pharmacol Ther 1997, 22:125–130.

    Google Scholar 

  39. Greenberg RN: Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984, 6:592–599.

    PubMed  CAS  Google Scholar 

  40. Schedlbauer A, Schroeder K, Peters TJ, Fahey T: Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2006, (4):CD004371.

  41. Haynes RB, Yao X, Degani A, et al.: Interventions to enhance medication adherence. Cochrane Database Syst Rev 2005, (4):CD000011.

  42. Pearson TA, Bazzarre TL, Daniels SR, et al.: American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003, 107:645–651.

    Article  PubMed  Google Scholar 

  43. Wagner EH, Austin BT, Von Korff M: Organizing care for patients with chronic illness. Milbank Q 1996, 74:511–544.

    Article  PubMed  CAS  Google Scholar 

  44. Smith SC Jr, Jackson R, Pearson TA, et al.: Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation 2004, 109:3112–3121.

    Article  PubMed  Google Scholar 

  45. Smith SC Jr, Allen J, Blair SN, et al.: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113:2363–2372.

    Article  PubMed  Google Scholar 

  46. Mosca L, Banka CL, Benjamin EJ, et al.: Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007, 115:1481–1501.

    Article  PubMed  Google Scholar 

  47. Yancey AK, Robinson RG, Ross RK, et al.: Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing Group. Circulation 2005, 111:e140–e149.

    Article  PubMed  Google Scholar 

  48. Grundy SM, Howard B, Smith S Jr, et al.: Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002, 105:2231–2239.

    Article  PubMed  Google Scholar 

  49. Grundy SM, Hansen B, Smith SC Jr, et al.: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004, 551–556.

  50. Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252.

    Article  PubMed  CAS  Google Scholar 

  51. Williams MA, Fleg JL, Ades PA, et al.: Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or = 75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002, 105:1735–1743.

    Article  PubMed  Google Scholar 

  52. Ockene IS, Miller NH: Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997, 96:3243–3247.

    PubMed  CAS  Google Scholar 

  53. Daniels SR, Arnett DK, Eckel RH, et al.: Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005, 111:1999–2012.

    Article  PubMed  Google Scholar 

  54. Kavey RE, Daniels SR, Lauer RM, et al.: American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003, 107:1562–1566.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Box 644, 601 Elmwood Avenue, Rochester, NY, 14642, USA

    Robert C. Block MD, MPH

Authors
  1. Robert C. Block MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas A. Pearson MD, MPH, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert C. Block MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Block, R.C., Pearson, T.A. Organizing services for cardiovascular prevention. Curr Treat Options Cardio Med 9, 278–286 (2007). https://doi.org/10.1007/s11936-007-0023-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-007-0023-4

Keywords

Search

Navigation